-
New Japanese Encephalitis Vaccine ‘A Historic Moment for Global Health’
As I prepare for retirement this month and reflect on my four years as the director of the neglected infectious diseases team here at the Bill & Melinda Gates Foundation, one of the things I am most proud of is to have been part of a global team that has been working to get a new Japanese encephalitis vaccine to the millions of people who need it.
- Categories
- Health Care
- Region
- Asia Pacific
- Tags
- vaccines
-
Chinese Pharma: A Global Health Game Changer?
The twenty-first century shift in geoeconomic power toward Asia has also spurred a rebalancing in global pharmaceutical research and development (R&D) investment toward emerging economies. China is currently the world’s second-highest investor in R&D and is poised to overtake the United States in R&D spending by 2023. Determined to become a world leader in the pharmaceutical sector, China spent $1.17 billion on promoting life and medical sciences in 2012—nearly ten times its 2004 level of investment. With U.S. funding for medical research on the decline, the surge in Chinese funding has prompted many policymakers to ask if the country's pharmaceutical industry could be the next game changer for global public health and access to medicine (ATM).
- Categories
- Education, Health Care
- Region
- South Asia
- Tags
- research
-
The Healthiest (and Least Healthy) Countries in the World
World Health Day is on April 7, and people around the globe are turning their attention to health issues. The global infant mortality rate of 33.6 deaths per 1,000 live births in 2013 has followed a long-term downward trend. Similarly, life expectancy has improved dramatically in recent decades. The improvements were uneven, however, and health conditions continue to vary widely between nations.
- Categories
- Health Care
- Tags
- infrastructure, nutrition
-
Crucial Vaccines Out of Reach for Many in Rural India
The Union health ministry's ambitious Mission Indradhanush to immunise children against various diseases faces a major challenge as the Hib vaccine to safeguard the little ones from deadly infections like meningitis, pneumonia and severe throat conditions remains out of the reach in vast areas of the country.
- Categories
- Health Care
- Region
- South Asia
-
Superslick Coatings Conquer Ketchup, But What About Ebola?
The videos are almost unbelievable. Ketchup slides out of the jar and you don't even have to give it a thump. Glue slips out of the bottle without a molecule left inside. And what about getting that last smidgen of toothpaste from a used tube? No problem.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Simpler Antibiotic Regimen Helps Sick Babies in Developing Nations
Newborns and young infants in developing nations who have suspected severe bacterial infections can be effectively treated outside a hospital, two new studies suggest.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
India to Add More AIDS, TB Drugs to Essential Medicines List
India is likely to add more HIV/AIDS and tuberculosis drugs to its list of essential medicines that are subject to price caps, people directly involved in the process said, in a move to improve affordability of drugs to treat the deadly diseases.
- Categories
- Health Care
- Region
- South Asia
-
GlaxoSmithKline and Merck Ebola Vaccines Succeed in Phase II Liberian Trials
Two Ebola vaccines, one developed by the NIH and GlaxoSmithKline ($GSK) and the other by Merck ($MRK) and NewLink ($NLNK), have sailed through Liberian trials and, based on the results, may now advance to Phase III trials.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.